business strategy

News

Teva is eyeing $2.5bn in Austedo sales in 2027

The management of Israeli pharma group Teva has laid out its strategy for a return to growth after a challenging few years, with a greater emphasis on innovative medicines

Sales & Marketing

Business strategy and forecasting team: Ally or adversary?

It’s 2023 and pharma is moving ahead and leaving behind the COVID-19 aftermath.

R&D

Strategies in securing funding for rare disease research

An outline of emerging financing strategies for rare disease research in challenging times.

Views & Analysis

AI’s infiltration of pharma: How COVID-19 accelerated change

The pharmaceutical industry has sometimes been a laggard in terms of digital maturity, but the COVID-19 crisis has provided companies the impetus to rapidly implement the most cutting-edge

Teva is eyeing $2.5bn in Austedo sales in 2027

Business strategy and forecasting team: Ally or adversary?

Strategies in securing funding for rare disease research

AI’s infiltration of pharma: How COVID-19 accelerated change

Ex-BioNTech execs launch 'AI-native' cancer company

Discover a new era of healthcare panel engagement: Grounded ...

business strategy

Editor's Picks